Long-term Outcomes After Conversion to Belatacept

NCT04733131 · clinicaltrials.gov ↗

UNKNOWN

Status

324

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant Failure and Rejection
Immunosuppression
Graft Loss
Drug Effect Prolonged

Interventions

DRUG: Conversion to a belatacept regimen

Sponsor

Paris Translational Research Center for Organ Transplantation